These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38163890)

  • 21. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
    Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z
    FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?
    Frega S; Bonanno L; Guarneri V; Conte P; Pasello G
    Crit Rev Oncol Hematol; 2018 Aug; 128():19-29. PubMed ID: 29958628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applicability of the lung-molGPA index in non-small cell lung cancer patients with different gene alterations and brain metastases.
    Chen K; Yu X; Zhang F; Xu Y; Zhang P; Huang Z; Fan Y
    Lung Cancer; 2018 Nov; 125():8-13. PubMed ID: 30429042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan.
    Yoshida H; Kim YH; Iwatsubo S; Sakaguchi C; Sakamori Y; Nagai H; Ozasa H; Mio T; Hirai T
    Oncology; 2020; 98(7):460-467. PubMed ID: 32222702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
    Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
    Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
    Xu P; Xiao H; Yang Q; Hu R; Jiang L; Bi R; Jiang X; Wang L; Mei J; Ding F; Huang J
    Exp Mol Med; 2020 Jan; 52(1):41-55. PubMed ID: 31956270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer.
    Yang J; Yang C; Zhang S; Mei Z; Shi M; Sun S; Shi L; Wang Z; Wang Y; Li Z; Xie C
    Cancer Biol Ther; 2015; 16(8):1194-204. PubMed ID: 26054751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8.
    Li C; Zheng H; Xiong J; Huang Y; Li H; Jin H; Ai S; Wang Y; Su T; Sun G; Xiao X; Fu T; Wang Y; Gao X; Liang P
    Cell Death Dis; 2022 Aug; 13(8):699. PubMed ID: 35961957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
    Huang RSP; Harries L; Decker B; Hiemenz MC; Murugesan K; Creeden J; Tolba K; Stabile LP; Ramkissoon SH; Burns TF; Ross JS
    Oncologist; 2022 Oct; 27(10):839-848. PubMed ID: 35598205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
    Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
    Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin.
    Bosch-Barrera J; Sais E; Cañete N; Marruecos J; Cuyàs E; Izquierdo A; Porta R; Haro M; Brunet J; Pedraza S; Menendez JA
    Oncotarget; 2016 May; 7(22):32006-14. PubMed ID: 26959886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer.
    Zhang Y; Sun Z; Zhang Y; Fu T; Liu C; Liu Y; Lin Y
    Biomed Pharmacother; 2016 Dec; 84():1274-1281. PubMed ID: 27810784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases.
    Yang Z; Guo Q; Wang Y; Chen K; Zhang L; Cheng Z; Xu Y; Yin X; Bai Y; Rabbie S; Kim DW; Ahn MJ; Yang JC; Zhang X
    Sci Transl Med; 2016 Dec; 8(368):368ra172. PubMed ID: 27928026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
    Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
    Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of EGFR Mutation Status and Brain Metastasis for Non-Small Cell Lung Cancer Treated with Ramucirumab plus Docetaxel.
    Furuya N; Ito K; Sakaguchi T; Hida N; Kakinuma K; Morikawa K; Inoue T; Komase Y; Hataji O; Mineshita M
    Oncology; 2020; 98(9):661-668. PubMed ID: 32464632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
    Zeng YD; Liao H; Qin T; Zhang L; Wei WD; Liang JZ; Xu F; Dinglin XX; Ma SX; Chen LK
    Oncotarget; 2015 Apr; 6(10):8366-76. PubMed ID: 25788260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
    Dempke WC; Edvardsen K; Lu S; Reinmuth N; Reck M; Inoue A
    Anticancer Res; 2015 Nov; 35(11):5797-806. PubMed ID: 26504000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier.
    Wang X; Mao W; Wang Z; Li X; Xiong Y; Lu H; Wang X; Yin H; Cao X; Xin H
    Int J Nanomedicine; 2020; 15():5491-5501. PubMed ID: 32848385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Front-line therapy for brain metastases and non-brain metastases in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: a network meta-analysis.
    Zhu Y; Liu C; Xu Z; Zou Z; Xie T; Xing P; Wang L; Li J
    Chin Med J (Engl); 2023 Nov; 136(21):2551-2561. PubMed ID: 37160733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
    Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
    Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.